Turn Therapeutics Inc.

TTRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0002023016

SEC filings (opens in a new tab)

No open-market purchases or sales by Turn Therapeutics Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $8.48M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Turn Therapeutics Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of TTRX: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Q4 2025	Change
Holders	0	22	+22
Shares	0	466.5K	+466.5K
Value	$0	$1.84M	+$1.84M

New holders (22)

Institutions that held Turn Therapeutics Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to TTRX in Q4 2025
Institution	Shares	Value	% of portfolio
Millennium Management LLC	95,623	$376.8K	0.00%
Wellington Shields & Co., LLC	65,732	$259.0K	0.06%
DDFG, Inc	52,288	$206.0K	0.05%
Vanguard Group Inc	30,156	$118.8K	0.00%
XTX Topco Ltd	25,173	$99.2K	0.00%
Brown Brothers Harriman & Co	23,688	$93.3K	0.00%
Citadel Advisors LLC	20,986	$82.7K	0.00%
HighTower Advisors, LLC	19,684	$77.6K	0.00%
RVW Wealth, LLC	18,000	$70.9K	0.01%
Jane Street Group, LLC	17,169	$67.6K	0.00%
Geode Capital Management, LLC	17,142	$67.5K	0.00%
Miracle Mile Advisors, LLC	16,000	$63.0K	0.00%
Tamar Securities, LLC	15,000	$59.1K	0.01%
Bank of America Corp	14,124	$55.6K	0.00%
LPL Financial LLC	13,000	$51.2K	0.00%
Morgan Stanley	10,000	$39.4K	0.00%
Hodges Capital Management Inc.	10,000	$39.4K	0.00%
Ronald Blue Trust, Inc.	1,122	$4.42K	0.00%
Wells Fargo & Company	1,000	$3.94K	0.00%
Royal Bank of Canada	267	$1.00K	0.00%
Pflug Koory, LLC	170	$670	0.00%
Tower Research Capital LLC (TRC)	137	$540	0.00%

Sold out (0)

Institutions that held Turn Therapeutics Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

None.